Researchers developed a new way to produce an anti-cancer enzyme called L-asparaginase using a fungus called Rhizopus, which could offer a safer alternative to current bacterial sources. They designed and tested a special bioreactor system that allows the fungus to grow as a biofilm, significantly increasing enzyme production. The system achieved enzyme activity levels much higher than previous laboratory methods, suggesting it could be scaled up for industrial pharmaceutical production.